In the United States, a vitamin C kojic acid body serum is regulated as a cosmetic under the Federal Food, Drug, and Cosmetic Act — provided your marketing claims remain in cosmetic territory. The line between cosmetic and drug is determined by intended use, which is established primarily through labeling and marketing copy, not ingredients.
Safe cosmetic claims for this type of product include: 'brightens the appearance of skin,' 'promotes an even-looking skin tone,' 'helps skin look more radiant,' and 'reduces the visible appearance of dark spots.' These describe a temporary, aesthetic change to appearance — the legal definition of a cosmetic effect. Problematic claims that push the product into drug territory include: 'treats hyperpigmentation,' 'clinically lightens skin,' 'reduces melanin production,' or any claim that implies the product affects the structure or function of the body. If your Instagram captions or website make drug-adjacent claims, the FDA can take enforcement action even if your label is compliant, because the agency considers all marketing materials when determining intended use.
Under the Modernization of Cosmetics Regulation Act (MoCRA), signed into law in December 2022, cosmetic brands now have additional obligations: facility registration, product listing, adverse event reporting, and maintaining safety substantiation records. These apply to your private label serum even if a contract manufacturer makes it — the responsible party (your brand) must comply.
In the European Union, kojic acid is restricted under Annex III of the EU Cosmetics Regulation, meaning it can be used up to specified limits under specified conditions. The notification through the Cosmetic Products Notification Portal (CPNP) is required before you place the product on the EU market, and a qualified Responsible Person in the EU must be appointed. The EU distinguishes drugs (medicinal products) from cosmetics similarly to the U.S., based on intended use, and 'skin lightening' claims in some EU member states are more tightly scrutinized than in the U.S.
In Canada, Health Canada classifies some skin-lightening ingredients as drug ingredients when above specified concentrations; kojic acid's status there should be confirmed with a Canadian regulatory consultant before launch.
The common mistake first-timers make is assuming the ingredient determines the regulatory category. It does not — the claim does. A product with kojic acid making only cosmetic claims is a cosmetic. The same product claiming to 'treat melasma' becomes a drug overnight, triggering an entirely different regulatory framework including clinical evidence requirements.
AJ Cosmo Labs connects brands with suppliers who understand these distinctions and can flag when a proposed claim is likely to create regulatory risk before you go to print.
Ingredients in this answer: Kojic Acid
Read the full guide on Private Label Vitamin C Kojic Acid Body Serum Low MOQ →